Stay updated with breaking news from Chas Schultz. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Crinetics Pharmaceuticals Appoints Dana Pizzuti, M.D. as Chief Development Officer - read this article along with other careers information, tips and advice on BioSpace
12.08.2022 - Paltusotine’s Phase 3 PATHFNDR Program in Acromegaly and Phase 2 Program in Carcinoid Syndrome Remain on Track for Top-Line Data in 2023 CRN04894 Phase 1 Data Demonstrated Pharmacologic Proof-of-Concept for Further Development in Both Cushing’s ...
SAN DIEGO, July 12, 2022 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on July 12, 2022, the Compensation...
Late-breaking presentation of analysis of SCORED clinical trial data describes significant reduction in cardiovascular death, myocardial infarction and...
21.03.2022 - Late-breaking clinical trial presentation by Deepak L. Bhatt, M.D., M.P.H., will describe new analysis of rates of CV death, myocardial infarction and stroke in the SCORED trialTHE WOODLANDS, Texas, March 21, 2022 (GLOBE NEWSWIRE) - Lexicon ...